Peroxisomal disorders: Clinical commentary and future prospects

American Journal of Medical Genetics

Volumn 30, Issue 3, 1988, Pages 771-792

  Wilson, G N ^a   Holmes, R D ^a   Hajra, A K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; CHILD; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID OXIDATION; HEREDITY; HUMAN; INFANT; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; ZELLWEGER SYNDROME;

EID: 0023748882     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1320300311     Document Type: Review

References (127)

1. Applegarth DA, Dimmick JR (1985): Adrenoleukodystrophy, cerebrohepatorenal syndrome (Zellweger syndrome), and peroxisomes. Pediatr Pathol 3: 377–378.
2. Appelkvist E‐L (1987): Dolichol biosynthesis in rat liver peroxisomes. Acta Chem Scand B41: 73–75.
3. Arias JA, Moser AB, Goldfischer SL (1985): Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders. J Cell Biol 100: 1789–1792.
4. Aubourg P (1987): Les maladies peroxysomiales. La Presse Méd 16: 391–397.
5. Aubourg P, Sack GH, Jr, Meyers DA, Lease JJ, Moser HW (1987): Linkage of adrenoleukodystrophy to a polymorphic DNA probe. Ann Neurol 21: 344–352.
6. Aveldano MI (1987): A novel group of very long chain polyenoic fatty acids in dipolyunsaturated phosphatidyl‐cholines from vertebrate retina. J Biol Chem 262: 1172–1179.
7. Barth PG, Schutgens RBH, Bakkeren JAJM, Dingemans KP, Heymans HSA, Douwes AC, Klei‐van Moorsel JMVD (1985): A milder variant of Zellweger syndrome. Eur J Pediatr 144: 338–342.
8. Beard ME, Holtzman E (1987): Peroxisomes in wild‐type and rosy mutant Drosophila melanogaster. Proc Natl Acad Sci USA 84: 7433–7473.
9. Bellion E, Goodman JM (1987): Proton ionophores prevent assembly of a peroxisomal protein. Cell 48: 165–173.
10. Black VH, Cornacchia L III (1986): Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal‐onset adrenoleukodystrophy. Am J Anat 177: 107–118.
11. Bjorkhem I, Blomstrand S, Glaumann H, Strandvik B (1985): Unsuccessful attempts to induce peroxisomes in two cases of Zellweger disease by treatment with clofibrate. Pediatr Res 19: 590–594.
12. Bjorkhem I, Sisfontes L, Bostrom B, Kase BF, Blomstrand R (1986): Simple diagnosis of the Zellweger syndrome by gas‐liquid chromatography of dimethylacetals. J Lipid Res 27: 786–791.
13. Borst P (1986): How proteins get into microbodies (Peroxisomes, glyoxysomes, glycosomes). Biochim Biophys Acta 866: 179–203.
14. Boué J, Oberle I, Heilig R, Mandel JL, Moser A, Moser H, Larsen JW, Jr, Dumez Y, Boué A (1985): First trimester diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe. Hum Genet 69: 272–274.
15. Bowen P, Lee CSH, Zellweger H, Lindenberg R (1964): A familial syndrome of multiple congenital defects. Bull Johns Hopkins 114: 402–414.
16. Breidenbach RW, Beevers H (1967): Association of the glyoxylate cycle enzymes in a novel subcellular particle from castor bean endosperm. Biochem Biophys Res Commun 27: 462–469.
17. Briere N (1986): Peroxisomes in human fetal kidney: Variations in size and number during development. Anat Embryol (Ber 1) 174: 235–242.
18. Brown FR III, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982): Cerebrohepato‐renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: Similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J 151: 344–361.
19. Cavalier‐Smith T (1987): The simultaneous symbiotic origin of mitochondria, chloroplasts, and microbodies. Ann NY Acad Sci 503: 55–71.
20. Chen WW, Watkins PC, Osumi T, Hashimoto T, Moser HW (1987): Peroxisomal B‐oxidation enzyme proteins in adrenoleukodystrophy: Distinction between X‐linked adrenoleukodystrophy and neonatal adrenoleukodystrophy. Proc Natl Acad Sci USA 84: 1425–1428.
21. Curry CJR, Magenis RE, Brown M, Lanman JT, Jr, Tsai J, O'Lague P, Goodfellow P, Mohandas T, Bergner EA, Shapiro LJ (1984): Inherited chondrodysplasia punctata due to a deletion of the terminal short arm of an X chromosome. N Engl J Med 311: 1010–1015.
22. Danks DM, Tippet P, Adams C, Campbell P (1975): Cerebro‐hepato‐renal syndrome of Zellweger. A report of eight cases with comments on the incidence, the liver lesion and a fault in pipecolic acid metabolism. J Pediatr 86: 382–387.
23. Danpure CJ, Jennings PR (1986): Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201: 20–24.
24. Datta NS, Wilson GN, Hajra AK (1984): Deficiency of enzymes catalyzing the biosynthesis of glycerol ether lipids in Zellweger syndrome: A new category of metabolic disease involving the absence of peroxisomes. N Engl J Med 311: 1080–1083.
25. de Duve C, Baudhin P (1966): Peroxisomes (microbodies and related particles). Physiol Rev 46: 323–357.
26. de Duve C, Beaufay H, Jacques P, Rahman‐Li Y, Sellinger OZ, Wattiaux R, de Cominck S (1960): Intracellular localization of catalase and of some oxidases in rat liver. Biochim Biophys Acta 40: 186–187.
27. Diczfalusy U, Alexson SEH, Pedersen JI (1987): Chain‐shortening of prostaglandin F2 by rat liver peroxisomes. Biochem Biophys Res Commun 144: 1206–1213.
28. Ek J, Rase BF, Reith A, Bjorkhem I, Pedersen JI (1986): Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): Clinical and biochemical findings similar to those observed in Zellweger syndrome. J Pediatr 108: 18–24.
29. Eyssen H, Parmentier G, Compernolle F, Boon K, Eggermont E (1972): Trihydroxycoprostanoic acid in the duodenal fluid of two children with intrahepatic duct anomalies. Biochem Biophys Acta 273: 212–221.
30. Fujiki Y, Fowler S, Shio H, Hubbard AL, Lazarow PB (1982): Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: Comparison with endoplasmic reticulum and mitochondrial membranes. J Cell Biol 93: 103–110.
31. Fujiki Y, Rachubinski RA, Lazarow PB (1984): Synthesis of a major integral membrane polypeptide of rat liver peroxisomes on free polysomes. Proc Natl Acad Sci USA 81: 7127–7131.
32. Gatfield PD, Talleer E, Hinton GG, Wallace AC, Abdelnour GM, Haust MD (1968): Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. Can Med Assoc J 99: 1215–1233.
33. Ghosh MK, Hajra AK (1986): A rapid method for the isolation of peroxisomes from rat liver. Anal Biochem 159: 169–174.
34. Goldfischer S (1986): Letter to the editor. N Engl J Med 315: 766–767.
35. Goldfischer S, Collins J, Rapin I, Coltoff‐Schiller B, Chang C‐H, Nigro M, Black VH, Javitt NB, Moser HW, Lazarow PB (1985): Peroxisomal defects in neonatal‐onset and X‐linked adrenoleukodystrophies. Science 227: 67–70.
36. Goldfischer S, Collins J, Rapin I, Neumann P, Neglia W, Spiro AJ, Ishii T, Roels F, Vamecq J, Van Hoof F (1986): Pseudo‐Zellweger syndrome: Deficiences in several peroxisomal oxidative activities. J Pediatr 108: 25–32.
37. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973): Peroxisomal and mitochondrial defects in the cerebrohepatorenal syndrome. Science 182: 62–64.
38. Goldman BM, Blobel G (1978): Biogenesis of peroxisomes: Intracellular site of synthesis of catalase and uricase. Proc Natl Acad Sci USA 75: 5066–5070.
39. Goodman JM (1985): Dehydroxyacetone synthase is an abundant constituent of the methanol‐induced peroxisome of Candida boidinii. J Biol Chem 260: 7108–7113.
40. Govaerts L, Monnen L, Melis T, Trijbels F (1984): Disturbed adrenocortical function in cerebro‐hepatorenal syndrome of Zellweger. Eur J Pediatr 143: 10–12.
41. Greenberg C, Hajra AK, Moser AB (1987): Triple therapy of a patient with a generalized peroxisomal disorder. Am J Hum Genet 41 (suppl): A64.
42. Hagey LR, Krisans SK (1982): Degradation of cholesterol to propionic acid by rat liver peroxisomes. Biochem Biophys Res Commun 107: 834–841.
43. Hajra AK, Bishop JE (1982): Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann NY Acad Sci 386: 170–181.
44. Hajra AK, Burke CL, Jones CL (1979): Subcellular localization of acyl coenzyme A: Dehydroxyacetone phosphate acyltransferase in rat liver peroxisomes (microbodies). J Biol Chem 254: 10896–10900.
45. Hajra AK, Datta NS, Jackson LG, Moser AB, Moser HW, Larsen JW, Jr, Power J (1985): Prenatal diagnosis of Zellweger cerebrohepatorenal syndrome. N Engl J Med 312: 445–446.
46. Hanrahan DJ, Kumar R (1987): Platelet activating factor: Chemical and biochemical characteristics. Prog Lipid Res 26: 1–28.
47. Hanson RJ, Szczepanik‐van Leeuwen P, Williams GC, Grabowski G, Sharp HL (1979): Defects of bile acid synthesis in Zellweger's syndrome. Science 203: 1107–1110.
48. Happel R (1979): X‐linked dominant chondrodysplasia punctata. Review of literature and report of a case. Hum Genet 53: 65–73.
49. Hashimoto F, Hayashi H (1987): Significance of catalase in peroxisomal fatty acyl‐CoA B‐oxidation. Biochim Biophys Acta 921: 142–150.
50. Hashmi M, Stanley W, Singh I (1986): Lignoceroyl‐CoASH ligase‐enzyme defect in fatty acid beta‐oxidation system in X‐linked childhood adrenoleukodystrophy. FEBS Lett 196: 247–250.
51. Hess R, Staubli W, Riess W (1965): Nature of the hepatomegalic effect produced by ethyl‐chlorphenoxy‐isobutyrate in the rat. Nature 208: 856–858.
52. Heymans HSA, Oorthys JWE, Nelck G, Wanders RJA, Dingemans KP, Schutgens RBH (1986): Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata. J Inher Metabol Dis 9 (suppl 2): 329–331.
53. Heymans HSA, Oorthys JWE, Nelck G, Wanders RJA, Schutgens RBH (1985): Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder. N Engl J Med 313: 187–188.
54. Heymans HSA, Schutgens RBH, Tan R, Bosch H, Borst P (1983): Severe plasmalogen deficiency in infants without peroxisomes (Zellweger syndrome). Nature 306: 69–70.
55. Hockaday TDR, Clayton JE, Frederick EW, Smith IH, Jr (1964): Primary hyperoxaluria. Medicine 43: 315–323.
56. Hoganson G, Berlow S, Gilbert EF, Frerman F, Goodman S, Schweitzer L (1987): Glutaric aciduria type II and flavin‐dependent enzymes in morphogenesis. In Gilbert EF, Opitz JM (eds): “ Genetic Aspects of Developmental Pathology.” New York: Alan R. Liss for the National Foundation—March of Dimes, BD:OAS 23 (1): 65–74.
57. Holmes RD, Hajra AK, Wilson GN (1987a): Peroxisomal enzyme deficiency in the Conradi‐Hunerman form of chondrodysplasia punctata. N Engl J Med 316: 1608.
58. Holmes RD, Wilson GN, Hajra AK (1987b): Oral ether lipid therapy in patients with peroxisomal disorders. J Inher Metab Dis 2 (suppl): 239–241.
59. Holmes RD, Wilson GN, Hajra AK (1987c): Peroxisomal disorders: A true syndrome community. Am J Hum Genet (suppl) 41: A68.
60. Igarashi M, Schaumberg HH, Powers JM, Kishimoto Y, Kolodny E, Suzuki K (1976): Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26: 851–860.
61. Kahlke W, Goerlich R, Feist D (1974): Erhohte Phytansaurespiegel in Plasma und Leber beieonnem Kleinkind mit unklarem Hirnschaden. Klin Wschr 52: 651–653.
62. Kawamura N, Moser HW, Kishimoto Y (1981): Very long chain fatty acid oxidation in rat liver. Biochem Biophys Res Commun 99: 1216–1225.
63. Keller G‐A, Barton MC, Shapiro DJ, Singer SJ (1985): 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase is present in peroxisomes in normal rat liver cells. Proc Natl Acad Sci USA 82: 770–774.
64. Kelley RI (1983): The cerebro‐hepato‐renal syndrome of Zellweger: Morphologic and metabolic aspects. Am J Med Gen 16: 503–517.
65. Kelley RI, Datta NS, Dobyns WB, Hajra AK, Moser AB, Noetzel MJ, Zackai EH, Moser HW (1986): Neonatal adrenoleukodystrophy: New cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am J Med Genet 23: 869–901.
66. Labarca P, Wolff D, Soto U, Necochea C, Leighton F (1986): Large cation‐selective pores from rat liver peroxisomal membranes incorporated to planar bilayers. J Membr Biol 94: 285–291.
67. Lalwani ND, Reddy MK, Ghosh S, Barnard SD, Molello JA, Reddy JK (1985): Induction of fatty acid beta‐oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL‐040, a new hypolipidaemic agent. Biochem Pharmacol 34: 3473–3482.
68. Lam S, Hutzler J, Dancis J (1986): L‐Pipecolaturia in Zellweger syndrome. Biochim Biophys Acta 882: 254–257.
69. Lazarow PB, Black V, Shio H, Fujiki Y, Hajra AK, Datta NS, Bangaru BS, Dancis J (1985): Zellweger syndrome: Biochemical and morphological studies on two patients treated with clofibrate. Pediatr Res 19: 1356–1364.
70. Lazarow PB, de Duve C (1976): A fatty acyl‐CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73: 2043–2046.
71. Lazarow PB, Fujiki Y (1985): Biogenesis of peroxisomes. Ann Rev Cell Biol 1: 489–530.
72. Lazarow PB, Fujiki Y, Small GM, Watkins P, Moser H (1986): Presence of the peroxisomal 22‐kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome). Proc Natl Acad Sci USA 83: 9193–9196.
73. Lee T, Snyder F (1986): Function, metabolism and regulation of platelet activating factor and related ether lipids. In Kuo JF (ed): “ Phospholipids and Cellular Regulation.” Boca Raton: CRC Press, Inc. pp 1–39.
74. Lepoutre C (1925): Calculs multiples chez un enfant. Infiltration du parenchyme renal par des cristaux. J Urol 20: 424–427.
75. Litwin JA, Volkl A, Muller‐Hocker J, Hashimoto T, Fahimi HD (1987): Immunocytochemical localization of peroxisomal enzymes in human liver biopsies. Am J Pathol 128: 141–150.
76. Lubinsky M (1985): The syndrome as finding or cause: Suggested terminology. Am J Med Genet 20: 727–728.
77. Miura S, Mori M, Takiguchi M, Tatibana M, Furuta S, Miyazawa S, Hashimoto T (1984): Biosynthesis and intracellular transport of enzymes of peroxisomal β‐oxidation. J Biol Chem 259: 6397–6402.
78. Molzer B, Korschinsky M, Bernheimer H, Schmid R, Wolf C, Roscher A (1986): Very long chain fatty acids in genetic peroxisome disease fibroblasts: Differences between the cerebrohepatorenal (Zellweger syndrome) and adrenoleukodystrophy variants. Clin Chem Acta 161: 81–90.
79. Moser HW (1986): Peroxisomal disorders. J Pediatr 108: 89–91.
80. Moser HW (1987): New approaches in peroxisomal disorders. Dev Neurosci 9: 1–18.
81. Moser HW, Moser AB, Powers JM, Nitowsky HM, Schaumburg HH, Norum RA, Migeon BR (1982): The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in culture amniocytes and fetal adrenal gland. Pediatr Res 16: 172–175.
82. Moser HW, Moser AB, Singh I, O'Neill BP (1984): Adrenoleukodystrophy: Survey of 303 cases: Biochemistry, diagnosis and therapy. Ann Neurol 16: 628–641.
83. Moser AB, Singh I, Brown FR III, Solish GI, Kelley RI, Benke PJ, Moser HW (1984): The cerebrohepatorenal (Zellweger) syndrome: Increased levels and imparied degradation of very‐long‐chain fatty acids and their use in prenatal diagnosis. N Engl J Med 310: 1141–1146.
84. Opitz J (1985): The Zellweger syndrome: Book review and bibliography. Am J Med Genet 22: 419–416.
85. Osumi T, Ishii N, Hijikata M, Kamijo K, Ozasa H, Furuta S, Miyazawa S, Kondo K, Inoue K, Kagamiyama H, Hashimoto T (1986): Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enocy‐CoA: hydratase‐3‐hydroxyacyl‐CoA dehydrogenase bifunctional enzyme. J Biol Chem 260: 8905–8910.
86. Osumi T, Ozasa H, Hashimoto T (1984): Molecular cloning of cDNA for rat acyl‐CoA oxidase. J Biol Chem 259: 2031–2034.
87. Pinsky L (1975): The community of human malformation syndromes that shares ectodermal dysplasia and deformities of the hands and feet. Teratology 11: 227–242.
88. Poll‐The BT, Saudubray JM, Ogier H, Shutgens RBH, Wanders RJA, Schrakamp G, Bosch Hvd, Trijbels JMF, Poulos A, Moser HW, Eldere Jv, Eyssen JH (1986): Infantile Refsum's disease: Biochemical findings suggesting multiple peroxisome dysfunction. J Inher Metab Dis 9: 169–174.
89. Poulos A, Pollard AC, Mitchell JD, Wise D, Mortimer G (1984): Patterns of Refsum's disease: Phytanic acid oxidase deficiency. Arch Dis Child 59: 222–229.
90. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T, Hashimoto T, Lalwani ND, Rao MS (1986): Transcriptional regulation of peroxisomal fatty acyl‐CoA oxidase and enoyl‐CoA hydratase/3‐hydroxyacyl‐CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci USA 83: 1747–1751.
91. Reddy JK, Warren JR, Reddy MK, Lalwani ND (1982): Hepatic and renal effects of peroxisome proliferators: Biological implications. Ann NY Acad Sci 386: 81–110.
92. Refsum S (1946): Heredopathia atactica polyneuritiformis. Acta Psychiatr Neurol 38 (suppl): 1–303.
93. Rhodin J (1954): Correlation of ultrastructural organization and function in normal and experimentally changed proximal tubule cells of the mouse kidney. Doctoral thesis. Karolinska Institute. Stockholm. Akitbolaget Godvil.
94. Rocchiccioli F, Aubourg P, Bougneres PF (1986): Medium and long‐chain dicarboxylic aciduria in patients with Zellweger syndrome and neonatal adrenoleukodystrophy. Pediatr Res 20: 62–66.
95. Roscher A, Molzer B, Bernheimer H, Stockler S, Mutz I, Paltauf (1985): The cerebrohepatorenal (Zellweger) syndrome: An improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr Res 19: 930–933.
96. Schram AW, Goldfischer S, van Roermund CWT, Brouwer‐Kelder EM, Collins J, Hashimoto T, Heymans HSA, Bosch Hvd, Schutgens RBH, Tager JM, Wanders RJA (1987): Human peroxisomal 3‐oxoacyl‐coenzyme A thiolase deficiency. Proc Nat Acad Sci USA 84: 2494–2496.
97. Schram AW, Strijland A, Hashimoto T, Wanders RJA, Shutgens RBH, Bosch Hvd, Tager JM (1986): Biosynthesis and maturation of peroxisomal β‐oxidation enzymes in fibroblasts in relation to Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci USA 83: 6156–6158.
98. Schrakamp G, Schutgens RBH, Wanders RJA, Heymans HSA, Tager JM, Bosch Hvd (1985): The cerebro‐hepato‐renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts. Biochem Biophys Acta 833: 170–174.
99. Schutgens RHB, Heymans HSA, Wanders RJA, Bosch Hvd, Tager JM (1986): Peroxisomal disorders: A newly recognized group of genetic diseases. Eur J Pediatr 144: 430–440.
100. Schutgens RBH, Romeyn GJ, Wanders RJA, Bosch Hvd, Schrakamp G, Heymans HSA (1984): Deficiency of acyl CoA: Dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro‐hepato‐renal) syndrome. Biochem Biophys Res Commun 120: 179–184.
101. Sharp P, Poulos A, Fellenberg A, Johnson D (1987): Structure and lipid distribution of polyenoic very‐long‐chain fatty acids in the brain of peroxisome deficient patients. Biochem J 248: 61–67.
102. Siemerling E, Creutzfeldt HC (1923): Bronzekrankheit and Sklerosierende Encephalomyelitis (diffuse Sclerose). Arch Psychiatr 68: 217–244.
103. Spranger JW, Opitz JM, Bidder V (1971): Heterogeneity of chrondrodysplasia punctata. Hum Genet 11: 190–212.
104. Steinberg D (1983): Phytanic acid storage disease (Refsum's disease). In Stanburg JB, Wyngaarden JB, Frederickson DS, Goldstein JL, Brown MS (eds): “ The Metabolic Basis of Inherited Disease.” 5th edition. New York: McGraw‐Hill, pp 731–747.
105. Stevens CA, Carey JC, Shah M, Bagley GP (1987): Development of human palmar and digital flexion creases (abstract). David W. Smith Workshop on Malformations and Morphogenesis, Greenville, SC.
106. Stokke O, Skrede S, Ek J, Bjorkhem I (1984): Refsum's disease, adrenoleukodystrophy, and the Zellweger syndrome. Scand J Clin Lab Invest 44: 463–464.
107. Suzuki Y, Shimozawa N, Orii T, Aikawa J, Tada K, Kuwabara T, Hashimoto T (1987): Biosynthesis of peroxisomal membrane polypeptides in infants with Zellweger syndrome. J Inher Metab Dis 10: 297–300.
108. Tager JM, Westerveld A, Strigland A, Schram AW, Schutgens RBH, Bosch Hvd, Wanders RJA (1987): Complementation analysis of peroxisomal disease by somatic cell fusion. In Fahimi HO, Sies H (eds): “ Peroxisomes in Biology and Medicine.” Berlin: Springer, pp 353–357.
109. Thomas GH, Haslam RHA, Batshaw ML, Capute AJ, Neidengard L, Ransom JL (1975): Hyperpipecolic acidemia associated with hepatomegaly, mental retardation, optic nerve dysplasia, and progressive neurological disease. Clin Genet 8: 376–382.
110. Trijbels JMF, Monnens LAH, Melis G, Broek‐van Essen MVD, Bruckwilder M (1987): Localization of pipecolic acid metabolism in rat liver peroxisomes: Probable explanation for hyperpipecolatemia in Zellweger syndrome. J Inher Metab Dis 10: 128–134.
111. Ulrich J, Herschkowitz N, Hirtz P, Sigrist T, Baerlocher P (1978): Adrenoleukodystrophy. Preliminary report of a conatal case. Light and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol 43: 77–83.
112. Vamecq J, Draye J‐P, Van Hoof F, Nisson J‐P, Evrard P, Verellen G, Eyssen HJ, Eldere JV, Schutgens RBH, Wanders RJA, Roels F, Goldfischer SL (1986): Multiple peroxisomal enzymatic deficiency disorders: A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy. Am J Pathol 125: 524–535.
113. Vamecq J, Van Hoof F (1984): Implication of a peroxisomal enzyme in the catabolism of glutaryl‐CoA. Biochem J 221: 203–211.
114. Van den Branden C, Vamecq J, Wybo I, Roels F (1986): Phytol and peroxisome proliferation. Pediatr Res 20: 411–415.
115. Van Veldhoven PP, Just WW, Mannaerts GP (1987): Permeability of the peroxisomal membrane to cofactors of B‐oxidation. J Biol Chem 262: 4310–4318.
116. Versmold HT, Bremer HJ, Herzog V, Siegel G, von Bassewitz DB, Irle U, van Voss H, Lombeck I, Brauser B (1977): A metabolic disorder similar to Zellweger syndrome with hepatic acatalasia and absence of peroxisomes, altered content and redox state of cytochromes, and infantile cirrhosis with hemosiderosis. Eur J Pediatr 124: 261–275.
117. Wanders RJA, Purvis YR, Heymans HSA, Bakkeren JAJM, Parmentier GG, Eldere Jv, Eyssen H, Bosch Hvd, Tager JM, Schutgens RBH (1986a): Age‐related differences in plasmalogen content of erythrocytes from patients with the cerebro‐hepato‐renal (Zellweger) syndrome: Implications for postnatal detection of the disease. J Inher Metabl Dis 9: 335–342.
118. Wanders RJA, Saelman D, Heymans HSA, Schutgens RBH, Westerveld A, Poll‐The BT, Saudubray JM, Bosch Hvd, Strijland A, Schram AW, Tager JM (1986b): Genetic relation between the Zellweger syndrome, infantile Refsum's disease and rhizomelic chondrodysplasia punctata. N Engl J Med 314: 787–788.
119. Wanders RJA, Schrakamp G, Bosch Hvd, Tager JM, Schutgens RBH (1986c): A prenatal test for the cerebrohepatorenal (Zellweger) syndrome by demonstration of the absence of catalase‐containing particles (peroxisomes) in cultured amniotic fluid cells. Eur J Pediatr 145: 136–138.
120. Wanders RJA, Schutgens BH, Schrakamp G, Bosch Hvd, Tager JM, Schram AW, Poll‐The BT, Saudubray JM (1986d): Infantile Refsum disease: Deficiency of catalase‐containing particles (peroxisomes), alkyldihydroxyacetone phsophate synthase, and peroxisomal beta‐oxidation enzyme proteins. Eur J Pediatri 145: 172–175.
121. Webber KO, Datta NS, Hajra AK (1987): Properties of the enzymes catalyzing the biosynthesis of lysophosphatidate and its ether analog in cultured fibroblasts from Zellweger syndrome patients and normal controls. Arch Biochem Biophys, 254: 611–620.
122. Wilson GN (1986): What is Zellweger syndrome? J Pediatr 109398.
123. Wilson GN, Holmes RD, Custer J, Lipkowitz JL, Stover J, Datta N, Hajra A (1986): Zellweger syndrome: Diagnostic assays, syndrome delination, and potential therapy. Am J Med Genet 24: 69–82.
124. Yamada J, Ogawa S, Horie S, Watanabe T, Suga T (1987): Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial β‐oxidation of ω‐phenyl fatty acids in rat liver. Biochim Biophys Acta 921: 292–301.
125. Yamamoto K, Fahimi HD (1987): Three‐dimensional reconstruction of a peroxisomal reticulum in regenerating rat liver: Evidence of interconnections between heterogenous segments. J Cell Biol 105: 713–722.
126. Zellweger H (1987): The cerebro‐hepato‐renal (Zellweger) syndrome and other peroxisomal disorders. Dev Med Child Neurol 29: 821–829.
127. Zoeller RA, Raetz CRH (1986): Isolation of animal cell mutants deficient in plasmalogen biosynthesis and peroxisome assembly. Proc Natl Acad Sci USA 83: 5170–5174.